![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2021
Anzahl der Publikationen: 1
2021
Collins, Graham P.; Eyre, Toby A.; Schmitz-Rohmer, Debora; Townsend, William; Popat, Rakesh; Giulino-Roth, Lisa; Fieds, Paul A.; Krasniqi, Fatime; Soussain, Carole; Sathis, Anastasios; Andjelkovic, Nebojsa; Cuniingham, David; Mandic, Danijela; Radulovic, Sinisa; Tijanic, Ivan; Horowitz, Netanel A.; Kurtovic, Sabira; Schorb, Elisabeth; Schmidt, Christian; Dimitrijevic, Sasa und Dreyling, Martin
(2021):
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma.
In: Hemasphere, Bd. 5, Nr. 11, e656